Liquidia Corporation announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for YUTREPIA™ (treprostinil) inhalation powder to treat ...

You can say a lot with three letters. A-OK can tell others that you’re coping in times of trouble. WTF can tell them that you’re shocked. And TBT can tell them that you’re desperate for Instagram ...

J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to $90 million of revenue could be at risk this year.